Cartesian Therapeutics

Cartesian Therapeutics (NASDAQ: RNAC)

This biotechnology company develops messenger RNA cell therapies for patients with autoimmune diseases and respiratory disorders.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Chord Therapeutics

This clinical-stage biopharmaceutical company develops drugs for patients with rare neuroinflammatory diseases, including neuromyelitis optica spectrum disorder and generalized myasthenia gravis.

Cabaletta Bio

This clinical-stage biotechnology company develops engineered T cell therapies for patients with various autoimmune diseases.

Vor Bio

This biotechnology company develops therapies for patients living with serious autoantibody-driven autoimmune diseases, such as myasthenia gravis and Sjögren's disease.

ARTHEx Biotech

This clinical-stage biotechnology company develops RNA-based treatments for patients with rare neuromuscular genetic diseases, including myotonic dystrophy type 1.

Strand Therapeutics

This biotechnology company develops programmable messenger RNA therapies for patients with solid tumours and autoimmune diseases.

Kyverna Therapeutics

This biopharmaceutical company develops chimeric antigen receptor T-cell therapies for patients with B-cell driven autoimmune diseases such as multiple sclerosis and lupus nephritis.